Archives: Speakers

Alexis Davin is a clinical optimization specialist at N-SIDE and a volunteer at the GCSG. His experience in clinical supply expanded quickly by solving day-to-day supply challenges of biopharma companies. He is passionate about how digitalization can improve the clinical supply industry and, ultimately, impact patients’ health. Alexis is also supporting the development of new digital solutions to solve supply chain issues in clinical trials, which offers him a strategic view on industry trends and internal processes.

Jan Talts has extensive R&D and management experience from academia, the biotech industry, and the health care sector. He earned his PhD in Animal Physiology at Uppsala University working with extracellular matrix molecules in development and disease and has since then held positions as Associate Professor at Lund University Medical Faculty, Associate Professor and Section Leader for Anatomy and Cell Biology at the Royal Veterinary and Agricultural University, Copenhagen, Chief Medical Staff, Clinical Pathology, Lund University Hospital, and Senior Scientist, Project Manager and ECA certified QA Manager at the Swedish Regenerative Medicine Company Xintela AB. During the last years, he has been with Amniotics AB, first as Senior Scientist, then Chief Quality Officer and now Chief Operating Officer. He is the inventor on several patents and has published articles in international journals such as Cell, Molecular Cell, EMBO J, and PNAS. Jan Talts is well familiarized with most aspects of Advanced Therapy Medicinal Product (ATMP) development and have hands on experience within the preclinical, CMC, and regulatory fields.

I am an international business lawyer with an important corporate and transactional practice within the LifeSciences industry, mainly dealing with clinical R&D, finance, manufacture and logistics. I am from Spain but trained and with practice in the US, Latin America and, more recently, in the Nordics. I developed a deep expertise on: (i) Trading, infrastructure, public bidding processes; (ii) M&A, patent licensing, tax strategies; (iii) Foreign trade, customs, international business practices; (iv) Intellectual Property, IP monetization, technology transfer; and (v) implementation of strategies for small biotechs to become global. Currently I am the Head of Legal Affairs & Compliance at Pila Pharma AB in Sweden.

Arrash is an academic paediatrician at Imperial College, and is Huma’s Global Clinical Director. His previous national roles included working at the Department of Health and NHS England/Improvement. His healthcare experience includes some of the largest healthcare projects to date, including the 7-day hospital services programme and a range of other national initiatives.

João is the group CEO of Mobilize Financial Services (previously called RCI Bank and Services), the captive bank of the Renault group, working for the brands of the Alliance.

Summary: Leader in digitization excellence and technology transformation for Clinical Supply Chain in Bristol Meyers Squibb. Results driven problem solver with cross-functional business expertise and technical knowledge, delivering success in energizing operational and systematic transformation.

Gordon Gregory III, CCRP began his career in the Document Management field of Clinical Research Operations in 2008. He moved quickly from a Document Management Associate, through various Clinical Trial Associate roles, into Global Trial Leadership as a Clinical Trial Manager and GCDO Trial Leader and is currently forming a group within Clinical Supply Chain to oversee all of the patient scheduling on Janssen’s CAR-T trials. In his 12 years in the industry, he has excelled at every turn and was even selected to be a part of the initial cohort of the GCDO Clinical Operations Leaders of Tomorrow Program.

Jeff joined PCI in 2014 and he manages the North American Business Development Team for PCI’s Manufacturing and Development services.  Jeff has over twenty-five years in the biotech and pharmaceutical industries and his career includes experience in the pharmaceutical discovery sciences, high throughput automation, clinical formulation development, and cGMP analytical and manufacturing contract services.  All his business development experience is in the aseptic manufacturing and analytical fields. Prior to his current role, Jeff was previously the Director of Global Business Development at AMRI (Drug Product). Jeff received a B.S. in Biology from Keene State College and a M.S. in Quality Systems from The New England College of Business.